rs745571869
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4BP6_Moderate
The NM_021098.3(CACNA1H):c.790A>G(p.Ser264Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,459,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 missense
NM_021098.3 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 1.39
Publications
2 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.29217649).
BP6
Variant 16-1198761-A-G is Benign according to our data. Variant chr16-1198761-A-G is described in ClinVar as Benign. ClinVar VariationId is 460187.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.751A>G | p.Ser251Gly | missense_variant | Exon 6 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.751A>G | p.Ser251Gly | missense_variant | Exon 6 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.790A>G | p.Ser264Gly | missense_variant | Exon 6 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*237A>G | non_coding_transcript_exon_variant | Exon 5 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.790A>G | non_coding_transcript_exon_variant | Exon 6 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711442.1 | n.*237A>G | 3_prime_UTR_variant | Exon 5 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD2 exomes AF: 0.00000407 AC: 1AN: 245520 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
245520
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1459396Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726008 show subpopulations
GnomAD4 exome
AF:
AC:
3
AN:
1459396
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
726008
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33464
American (AMR)
AF:
AC:
0
AN:
44614
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26080
East Asian (EAS)
AF:
AC:
0
AN:
39690
South Asian (SAS)
AF:
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
AC:
0
AN:
52004
Middle Eastern (MID)
AF:
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
3
AN:
1111246
Other (OTH)
AF:
AC:
0
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Mar 08, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;.;N;N
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;N
REVEL
Uncertain
Sift
Uncertain
D;.;D;D
Sift4G
Benign
T;.;T;T
Polyphen
D;.;B;B
Vest4
MutPred
Loss of catalytic residue at S264 (P = 0.1216);.;Loss of catalytic residue at S264 (P = 0.1216);Loss of catalytic residue at S264 (P = 0.1216);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.